Lifevantage Corporation (NASDAQ:LFVN) Shares Bought by Capital Management Corp VA

Capital Management Corp VA lifted its stake in shares of Lifevantage Corporation (NASDAQ:LFVN - Free Report) by 137.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 715,503 shares of the company's stock after buying an additional 413,918 shares during the period. Lifevantage makes up approximately 1.8% of Capital Management Corp VA's investment portfolio, making the stock its 25th biggest holding. Capital Management Corp VA owned 5.70% of Lifevantage worth $10,432,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Brown Advisory Inc. purchased a new stake in shares of Lifevantage during the first quarter worth about $150,000. Cannon Global Investment Management LLC purchased a new stake in shares of Lifevantage during the first quarter worth about $156,000. Cambridge Investment Research Advisors Inc. increased its stake in shares of Lifevantage by 23.2% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 12,867 shares of the company's stock worth $188,000 after purchasing an additional 2,421 shares in the last quarter. Hillsdale Investment Management Inc. increased its stake in shares of Lifevantage by 7.3% during the fourth quarter. Hillsdale Investment Management Inc. now owns 14,720 shares of the company's stock worth $258,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC purchased a new stake in shares of Lifevantage during the fourth quarter worth about $282,000. 35.32% of the stock is currently owned by institutional investors and hedge funds.

Lifevantage Price Performance

NASDAQ LFVN traded down $0.34 during trading hours on Friday, hitting $12.97. 91,806 shares of the company's stock traded hands, compared to its average volume of 159,496. Lifevantage Corporation has a 52-week low of $6.43 and a 52-week high of $27.38. The company has a market capitalization of $163.29 million, a PE ratio of 18.80 and a beta of 0.43. The firm's 50-day moving average is $12.75 and its 200-day moving average is $15.60.

Lifevantage (NASDAQ:LFVN - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.10. Lifevantage had a net margin of 4.12% and a return on equity of 34.67%. The company had revenue of $58.44 million for the quarter, compared to analyst estimates of $60.99 million.

Lifevantage Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 30th were issued a dividend of $0.045 per share. The ex-dividend date was Friday, May 30th. This is a positive change from Lifevantage's previous quarterly dividend of $0.04. This represents a $0.18 dividend on an annualized basis and a yield of 1.39%. Lifevantage's dividend payout ratio is 26.09%.

Insider Transactions at Lifevantage

In other Lifevantage news, CFO Carl Aure sold 2,746 shares of the stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $13.39, for a total value of $36,768.94. Following the sale, the chief financial officer directly owned 133,303 shares of the company's stock, valued at approximately $1,784,927.17. This represents a 2.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. 20.65% of the stock is currently owned by company insiders.

About Lifevantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.